From a Milwaukee Journal Sentinel online article:
“Dysautonomia is probably significantly more common than we realize,” says Jeremy Cutsforth-Gregory, a neurologist at Mayo Clinic in Rochester, Minnesota. “I think it’s significantly underdiagnosed.” In about half of POTS cases, he adds, the patient’s disease grows out of the immune response to an infection.
Ryan Cooley, a doctor and co-director of the Dysautonomia Center at Aurora Medical Center in Grafton, says detecting the disorder is especially challenging because “typically there isn’t a dominant symptom or physical finding.”
Perhaps the most common clue to the disorder is that patients find that when they stand up from a chair their heart races and they feel light-headed.
To read more: https://www.jsonline.com/story/news/2019/11/14/invisible-illness-leaves-millions-undiagnosed-barely-functioning/2507547001/
They found that these physically active mice had fewer inflammatory cells (leukocytes) than sedentary mice, an effect they traced to diminished activity of hematopoietic stem and progenitor cells (HSPCs). The lower activity of HSPCs was due at least in part to exercise-induced reduction in the levels of leptin, a hormone produced by fat tissue that regulates cells within the hematopoietic bone marrow niche.
As a consultant, I had profoundly failed to appreciate the experience of fatigue and apathy among patients. More than excessive tiredness, the fatigue was overwhelming, turning simple activities into insurmountable, exhausting challenges. It was frustrating and I fell into the trap of overexertion when I did have energy, thus exhausting myself and sabotaging the day’s recovery plan. Had staff not been so adept at encouraging me when I lacked energy and holding me back when I tried to overdo things, I would have squandered much valuable rehabilitation time. 
There can be few applications of digital technology more worthwhile than saving lives, but integrating digital technology into healthcare systems is uniquely complex. This episode provides an introduction to some of the challenges that healthcare providers face in their pursuit of digital innovation, and explores some of the paths forward.
The riders who had pedaled on an empty stomach, however, had incinerated about twice as much fat during each ride as the men who consumed the shake first. The riders all had burned about the same number of calories while pedaling, but more of those calories came from fat when the men did not eat first.
Medicare negotiation of prescription-drug prices would bring U.S. government policies in line with those of other high-income countries, and the idea is popular with both the public and policy analysts. But it would represent a sea change for pharmaceutical firms, which will maintain that any threat to their pricing power will slow innovation. 
Any customer with an active prescription and an Alexa-enabled device will be able to access the medication management skill on the device, a Giant Eagle spokesperson told CNBC. Rachel Jiang, who leads the Amazon Alexa health and wellness team, said the company began developing the skill after noticing that customers were using the devices to create medication reminders.
“What you want is more, small fat cells rather than fewer, large fat cells,” Jackson said. “A large fat cell is not a healthy fat cell. The center is farther away from an oxygen supply, it sends out bad signals and it can burst and release toxic contents.” Large fat cells are associated with insulin resistance, diabetes and inflammation, he added.
The purpose of the centers is to increase customers’ understanding of Medicare, match them with people who can talk with them about their benefits or new plans to enroll in, and access in-store annual wellness visits.
